Yale Jen
Stock Analyst at Laidlaw
(0.24)
# 4,190
Out of 4,386 analysts
74
Total ratings
27.4%
Success rate
-9.2%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KZIA Kazia Therapeutics | Initiated Coverage: Buy | $25 | $11.40 | +119.30% | 1 | Apr 15, 2026 | |
| FEMY Femasys | Initiated Coverage: Buy | $6.5 | $5.39 | +20.59% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiated Coverage: Buy | $22 | $2.91 | +656.01% | 1 | Sep 29, 2025 | |
| VKTX Viking Therapeutics | Reiterated: Buy | $110 | $29.24 | +276.20% | 3 | Aug 20, 2025 | |
| SNTI Senti Biosciences Holdings | Initiated Coverage: Buy | $5 | $0.9416 | n/a | 1 | Jun 6, 2025 | |
| ALDX Aldeyra Therapeutics | Reiterated: Buy | $11 | $1.74 | n/a | 4 | Apr 4, 2025 | |
| NVCT Nuvectis Pharma | Initiated Coverage: Buy | $19 | $9.42 | n/a | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiated Coverage: Buy | $10 | $6.98 | n/a | 1 | Feb 10, 2025 | |
| XAIR Beyond Air | Maintained: Buy | $16 → $100 | $0.4101 | n/a | 3 | Nov 12, 2024 | |
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $68 | $73.54 | n/a | 8 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $20 | $0.4701 | n/a | 5 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.24 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $48 | $101.53 | n/a | 1 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7549 | n/a | 1 | Jul 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $79 | $7.12 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $11.45 | n/a | 3 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.5 → $225 | $1.44 | n/a | 3 | Jun 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $25 | $0.0001 | n/a | 5 | Jun 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $0.7573 | n/a | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.53 | n/a | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.008 | n/a | 2 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $6.26 | n/a | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.00 | n/a | 3 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 → $10 | $0.01315 | n/a | 2 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $20 | $0.4421 | n/a | 3 | Mar 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.74 | $8.06 | n/a | 1 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.37 | n/a | 1 | Aug 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $6 → $8.5 | $1.43 | n/a | 2 | Jul 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Aug 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $1.39 | n/a | 1 | May 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $90 | $5.53 | n/a | 2 | Nov 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $5.06 | n/a | 1 | Sep 27, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.5 | $4.03 | n/a | 1 | Sep 16, 2014 |
Kazia Therapeutics
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $25
Current: $11.40
Upside: +119.30%
Femasys
Nov 20, 2025
Initiated Coverage: Buy
Price Target: $6.5
Current: $5.39
Upside: +20.59%
Nasus Pharma
Sep 29, 2025
Initiated Coverage: Buy
Price Target: $22
Current: $2.91
Upside: +656.01%
Viking Therapeutics
Aug 20, 2025
Reiterated: Buy
Price Target: $110
Current: $29.24
Upside: +276.20%
Senti Biosciences Holdings
Jun 6, 2025
Initiated Coverage: Buy
Price Target: $5
Current: $0.9416
Upside: n/a
Aldeyra Therapeutics
Apr 4, 2025
Reiterated: Buy
Price Target: $11
Current: $1.74
Upside: n/a
Nuvectis Pharma
Mar 17, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $9.42
Upside: n/a
Lifeward
Feb 10, 2025
Initiated Coverage: Buy
Price Target: $10
Current: $6.98
Upside: n/a
Beyond Air
Nov 12, 2024
Maintained: Buy
Price Target: $16 → $100
Current: $0.4101
Upside: n/a
Ionis Pharmaceuticals
Oct 8, 2024
Reiterated: Buy
Price Target: $68
Current: $73.54
Upside: n/a
Sep 27, 2024
Reiterated: Buy
Price Target: $22 → $20
Current: $0.4701
Upside: n/a
Jul 29, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.24
Upside: n/a
Jul 29, 2024
Initiated Coverage: Buy
Price Target: $48
Current: $101.53
Upside: n/a
Jul 23, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.7549
Upside: n/a
Jul 2, 2024
Reiterated: Buy
Price Target: $79
Current: $7.12
Upside: n/a
Jun 26, 2024
Reiterated: Buy
Price Target: $50
Current: $11.45
Upside: n/a
Jun 14, 2024
Reiterated: Buy
Price Target: $7.5 → $225
Current: $1.44
Upside: n/a
Jun 12, 2024
Maintained: Buy
Price Target: $11 → $25
Current: $0.0001
Upside: n/a
May 28, 2024
Initiated Coverage: Buy
Price Target: $25
Current: $0.7573
Upside: n/a
Dec 22, 2023
Downgraded: Hold
Price Target: n/a
Current: $4.53
Upside: n/a
Dec 12, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.008
Upside: n/a
Aug 28, 2023
Initiated Coverage: Buy
Price Target: $10
Current: $6.26
Upside: n/a
Aug 15, 2023
Downgraded: Hold
Price Target: n/a
Current: $2.00
Upside: n/a
Aug 7, 2023
Reiterated: Buy
Price Target: $30 → $10
Current: $0.01315
Upside: n/a
Mar 14, 2022
Reiterated: Buy
Price Target: $18 → $20
Current: $0.4421
Upside: n/a
Nov 9, 2020
Reiterated: Buy
Price Target: $5.74
Current: $8.06
Upside: n/a
Aug 24, 2020
Downgraded: Hold
Price Target: n/a
Current: $1.37
Upside: n/a
Jul 31, 2020
Maintained: Buy
Price Target: $6 → $8.5
Current: $1.43
Upside: n/a
Aug 9, 2019
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
May 20, 2019
Initiated Coverage: Buy
Price Target: $10
Current: $1.39
Upside: n/a
Nov 15, 2018
Maintained: Buy
Price Target: $4 → $90
Current: $5.53
Upside: n/a
Sep 27, 2016
Maintained: Hold
Price Target: n/a
Current: $5.06
Upside: n/a
Sep 16, 2014
Initiated Coverage: Buy
Price Target: $3.5
Current: $4.03
Upside: n/a